APO Research
Talk to an analyst

APO RESEARCH · REPORT

NK3 Receptor Antagonists

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global NK3 Receptor Antagonists Market Analysis and Forecast 2026-2032

23 December 2025199 pages

Choose your research edition.

Industry ResearchNK3 Receptor Antagonists Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal NK3 Receptor Antagonists Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal NK3 Receptor Antagonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal NK3 Receptor Antagonists Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal NK3 Receptor Antagonists Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global NK3 Receptor Antagonists market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for NK3 Receptor Antagonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for NK3 Receptor Antagonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for NK3 Receptor Antagonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for NK3 Receptor Antagonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of NK3 Receptor Antagonists include Astellas and Bayer etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for NK3 Receptor Antagonists, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of NK3 Receptor Antagonists, also provides the sales of main regions and countries. Of the upcoming market potential for NK3 Receptor Antagonists, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the NK3 Receptor Antagonists sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global NK3 Receptor Antagonists market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for NK3 Receptor Antagonists sales, projected growth trends, production technology, application and end-user industry.

NK3 Receptor Antagonists Segment by Company

Astellas

Bayer

NK3 Receptor Antagonists Segment by Type

45 mg Dose

30 mg Dose

NK3 Receptor Antagonists Segment by Application

Hospital

Specialty Clinic

NK3 Receptor Antagonists Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NK3 Receptor Antagonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NK3 Receptor Antagonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NK3 Receptor Antagonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of NK3 Receptor Antagonists in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of NK3 Receptor Antagonists manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, NK3 Receptor Antagonists sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global NK3 Receptor Antagonists Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 45 mg Dose Major Manufacturers Table 3. 30 mg Dose Major Manufacturers Table 4. Global NK3 Receptor Antagonists Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Specialty Clinic Major Manufacturers Table 7. NK3 Receptor Antagonists Industry Trends Table 8. NK3 Receptor Antagonists Industry Drivers Table 9. NK3 Receptor Antagonists Industry Opportunities and Challenges Table 10. NK3 Receptor Antagonists Industry Restraints Table 11. Global NK3 Receptor Antagonists Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global NK3 Receptor Antagonists Revenue by Region (2021-2026) & (US$ Million) Table 13. Global NK3 Receptor Antagonists Revenue by Region (2027-2032) & (US$ Million) Table 14. Global NK3 Receptor Antagonists Revenue Market Share by Region (2021-2026) Table 15. Global NK3 Receptor Antagonists Revenue Market Share by Region (2027-2032) Table 16. Global NK3 Receptor Antagonists Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global NK3 Receptor Antagonists Sales by Region (2021-2026) & (k units) Table 18. Global NK3 Receptor Antagonists Sales by Region (2027-2032) & (k units) Table 19. Global NK3 Receptor Antagonists Sales Market Share by Region (2021-2026) Table 20. Global NK3 Receptor Antagonists Sales Market Share by Region (2027-2032) Table 21. Global NK3 Receptor Antagonists Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global NK3 Receptor Antagonists Revenue Market Share by Manufacturers (2021-2026) Table 23. Global NK3 Receptor Antagonists Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global NK3 Receptor Antagonists Sales Market Share by Manufacturers (2021-2026) Table 25. Global NK3 Receptor Antagonists Sales Price (USD/unit) of Manufacturers (2021-2026) Table 26. Global NK3 Receptor Antagonists Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global NK3 Receptor Antagonists Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global NK3 Receptor Antagonists Manufacturers, Product Type & Application Table 29. Global NK3 Receptor Antagonists Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global NK3 Receptor Antagonists by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global NK3 Receptor Antagonists Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global NK3 Receptor Antagonists Revenue by Type (2021-2026) & (US$ Million) Table 34. Global NK3 Receptor Antagonists Revenue by Type (2027-2032) & (US$ Million) Table 35. Global NK3 Receptor Antagonists Revenue Market Share by Type (2021-2026) Table 36. Global NK3 Receptor Antagonists Revenue Market Share by Type (2027-2032) Table 37. Global NK3 Receptor Antagonists Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global NK3 Receptor Antagonists Sales by Type (2021-2026) & (k units) Table 39. Global NK3 Receptor Antagonists Sales by Type (2027-2032) & (k units) Table 40. Global NK3 Receptor Antagonists Sales Market Share by Type (2021-2026) Table 41. Global NK3 Receptor Antagonists Sales Market Share by Type (2027-2032) Table 42. Global NK3 Receptor Antagonists Price by Type (2021-2026) & (USD/unit) Table 43. Global NK3 Receptor Antagonists Price by Type (2027-2032) & (USD/unit) Table 44. Global NK3 Receptor Antagonists Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global NK3 Receptor Antagonists Revenue by Application (2021-2026) & (US$ Million) Table 46. Global NK3 Receptor Antagonists Revenue by Application (2027-2032) & (US$ Million) Table 47. Global NK3 Receptor Antagonists Revenue Market Share by Application (2021-2026) Table 48. Global NK3 Receptor Antagonists Revenue Market Share by Application (2027-2032) Table 49. Global NK3 Receptor Antagonists Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global NK3 Receptor Antagonists Sales by Application (2021-2026) & (k units) Table 51. Global NK3 Receptor Antagonists Sales by Application (2027-2032) & (k units) Table 52. Global NK3 Receptor Antagonists Sales Market Share by Application (2021-2026) Table 53. Global NK3 Receptor Antagonists Sales Market Share by Application (2027-2032) Table 54. Global NK3 Receptor Antagonists Price by Application (2021-2026) & (USD/unit) Table 55. Global NK3 Receptor Antagonists Price by Application (2027-2032) & (USD/unit) Table 56. Astellas Company Information Table 57. Astellas Business Overview Table 58. Astellas NK3 Receptor Antagonists Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 59. Astellas NK3 Receptor Antagonists Product Portfolio Table 60. Astellas Recent Development Table 61. Bayer Company Information Table 62. Bayer Business Overview Table 63. Bayer NK3 Receptor Antagonists Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 64. Bayer NK3 Receptor Antagonists Product Portfolio Table 65. Bayer Recent Development Table 66. North America NK3 Receptor Antagonists Revenue by Type (2021-2026) & (US$ Million) Table 67. North America NK3 Receptor Antagonists Revenue by Type (2027-2032) & (US$ Million) Table 68. North America NK3 Receptor Antagonists Sales by Type (2021-2026) & (k units) Table 69. North America NK3 Receptor Antagonists Sales by Type (2027-2032) & (k units) Table 70. North America NK3 Receptor Antagonists Sales Price by Type (2021-2026) & (USD/unit) Table 71. North America NK3 Receptor Antagonists Sales Price by Type (2027-2032) & (USD/unit) Table 72. North America NK3 Receptor Antagonists Revenue by Application (2021-2026) & (US$ Million) Table 73. North America NK3 Receptor Antagonists Revenue by Application (2027-2032) & (US$ Million) Table 74. North America NK3 Receptor Antagonists Sales by Application (2021-2026) & (k units) Table 75. North America NK3 Receptor Antagonists Sales by Application (2027-2032) & (k units) Table 76. North America NK3 Receptor Antagonists Sales Price by Application (2021-2026) & (USD/unit) Table 77. North America NK3 Receptor Antagonists Sales Price by Application (2027-2032) & (USD/unit) Table 78. North America NK3 Receptor Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 79. North America NK3 Receptor Antagonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 80. North America NK3 Receptor Antagonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 81. North America NK3 Receptor Antagonists Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 82. North America NK3 Receptor Antagonists Sales by Country (2021-2026) & (k units) Table 83. North America NK3 Receptor Antagonists Sales by Country (2027-2032) & (k units) Table 84. North America NK3 Receptor Antagonists Sales Price by Country (2021-2026) & (USD/unit) Table 85. North America NK3 Receptor Antagonists Sales Price by Country (2027-2032) & (USD/unit) Table 86. United States NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 87. Canada NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 88. Mexico NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 89. Europe NK3 Receptor Antagonists Revenue by Type (2021-2026) & (US$ Million) Table 90. Europe NK3 Receptor Antagonists Revenue by Type (2027-2032) & (US$ Million) Table 91. Europe NK3 Receptor Antagonists Sales by Type (2021-2026) & (k units) Table 92. Europe NK3 Receptor Antagonists Sales by Type (2027-2032) & (k units) Table 93. Europe NK3 Receptor Antagonists Sales Price by Type (2021-2026) & (USD/unit) Table 94. Europe NK3 Receptor Antagonists Sales Price by Type (2027-2032) & (USD/unit) Table 95. Europe NK3 Receptor Antagonists Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe NK3 Receptor Antagonists Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe NK3 Receptor Antagonists Sales by Application (2021-2026) & (k units) Table 98. Europe NK3 Receptor Antagonists Sales by Application (2027-2032) & (k units) Table 99. Europe NK3 Receptor Antagonists Sales Price by Application (2021-2026) & (USD/unit) Table 100. Europe NK3 Receptor Antagonists Sales Price by Application (2027-2032) & (USD/unit) Table 101. Europe NK3 Receptor Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe NK3 Receptor Antagonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 103. Europe NK3 Receptor Antagonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 104. Europe NK3 Receptor Antagonists Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 105. Europe NK3 Receptor Antagonists Sales by Country (2021-2026) & (k units) Table 106. Europe NK3 Receptor Antagonists Sales by Country (2027-2032) & (k units) Table 107. Europe NK3 Receptor Antagonists Sales Price by Country (2021-2026) & (USD/unit) Table 108. Europe NK3 Receptor Antagonists Sales Price by Country (2027-2032) & (USD/unit) Table 109. Germany NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 110. France NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 111. U.K. NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 112. Italy NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 113. Russia NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 114. Spain NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 115. Netherlands NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 116. Switzerland NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 117. Sweden NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 118. Poland NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 119. China NK3 Receptor Antagonists Revenue by Type (2021-2026) & (US$ Million) Table 120. China NK3 Receptor Antagonists Revenue by Type (2027-2032) & (US$ Million) Table 121. China NK3 Receptor Antagonists Sales by Type (2021-2026) & (k units) Table 122. China NK3 Receptor Antagonists Sales by Type (2027-2032) & (k units) Table 123. China NK3 Receptor Antagonists Sales Price by Type (2021-2026) & (USD/unit) Table 124. China NK3 Receptor Antagonists Sales Price by Type (2027-2032) & (USD/unit) Table 125. China NK3 Receptor Antagonists Revenue by Application (2021-2026) & (US$ Million) Table 126. China NK3 Receptor Antagonists Revenue by Application (2027-2032) & (US$ Million) Table 127. China NK3 Receptor Antagonists Sales by Application (2021-2026) & (k units) Table 128. China NK3 Receptor Antagonists Sales by Application (2027-2032) & (k units) Table 129. China NK3 Receptor Antagonists Sales Price by Application (2021-2026) & (USD/unit) Table 130. China NK3 Receptor Antagonists Sales Price by Application (2027-2032) & (USD/unit) Table 131. Asia NK3 Receptor Antagonists Revenue by Type (2021-2026) & (US$ Million) Table 132. Asia NK3 Receptor Antagonists Revenue by Type (2027-2032) & (US$ Million) Table 133. Asia NK3 Receptor Antagonists Sales by Type (2021-2026) & (k units) Table 134. Asia NK3 Receptor Antagonists Sales by Type (2027-2032) & (k units) Table 135. Asia NK3 Receptor Antagonists Sales Price by Type (2021-2026) & (USD/unit) Table 136. Asia NK3 Receptor Antagonists Sales Price by Type (2027-2032) & (USD/unit) Table 137. Asia NK3 Receptor Antagonists Revenue by Application (2021-2026) & (US$ Million) Table 138. Asia NK3 Receptor Antagonists Revenue by Application (2027-2032) & (US$ Million) Table 139. Asia NK3 Receptor Antagonists Sales by Application (2021-2026) & (k units) Table 140. Asia NK3 Receptor Antagonists Sales by Application (2027-2032) & (k units) Table 141. Asia NK3 Receptor Antagonists Sales Price by Application (2021-2026) & (USD/unit) Table 142. Asia NK3 Receptor Antagonists Sales Price by Application (2027-2032) & (USD/unit) Table 143. Asia NK3 Receptor Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Asia NK3 Receptor Antagonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. Asia NK3 Receptor Antagonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. Asia NK3 Receptor Antagonists Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 147. Asia NK3 Receptor Antagonists Sales by Country (2021-2026) & (k units) Table 148. Asia NK3 Receptor Antagonists Sales by Country (2027-2032) & (k units) Table 149. Asia NK3 Receptor Antagonists Sales Price by Country (2021-2026) & (USD/unit) Table 150. Asia NK3 Receptor Antagonists Sales Price by Country (2027-2032) & (USD/unit) Table 151. Japan NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 152. South Korea NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 153. India NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 154. Australia NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 155. Taiwan NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 156. Southeast Asia NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 157. SAMEA NK3 Receptor Antagonists Revenue by Type (2021-2026) & (US$ Million) Table 158. SAMEA NK3 Receptor Antagonists Revenue by Type (2027-2032) & (US$ Million) Table 159. SAMEA NK3 Receptor Antagonists Sales by Type (2021-2026) & (k units) Table 160. SAMEA NK3 Receptor Antagonists Sales by Type (2027-2032) & (k units) Table 161. SAMEA NK3 Receptor Antagonists Sales Price by Type (2021-2026) & (USD/unit) Table 162. SAMEA NK3 Receptor Antagonists Sales Price by Type (2027-2032) & (USD/unit) Table 163. SAMEA NK3 Receptor Antagonists Revenue by Application (2021-2026) & (US$ Million) Table 164. SAMEA NK3 Receptor Antagonists Revenue by Application (2027-2032) & (US$ Million) Table 165. SAMEA NK3 Receptor Antagonists Sales by Application (2021-2026) & (k units) Table 166. SAMEA NK3 Receptor Antagonists Sales by Application (2027-2032) & (k units) Table 167. SAMEA NK3 Receptor Antagonists Sales Price by Application (2021-2026) & (USD/unit) Table 168. SAMEA NK3 Receptor Antagonists Sales Price by Application (2027-2032) & (USD/unit) Table 169. SAMEA NK3 Receptor Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. SAMEA NK3 Receptor Antagonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. SAMEA NK3 Receptor Antagonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. SAMEA NK3 Receptor Antagonists Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 173. SAMEA NK3 Receptor Antagonists Sales by Country (2021-2026) & (k units) Table 174. SAMEA NK3 Receptor Antagonists Sales by Country (2027-2032) & (k units) Table 175. SAMEA NK3 Receptor Antagonists Sales Price by Country (2021-2026) & (USD/unit) Table 176. SAMEA NK3 Receptor Antagonists Sales Price by Country (2027-2032) & (USD/unit) Table 177. Brazil NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 178. Argentina NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 179. Chile NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 180. Colombia NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 181. Peru NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 182. Saudi Arabia NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 183. Israel NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 184. UAE NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 185. Turkey NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 186. Iran NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 187. Egypt NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 188. Key Raw Materials Table 189. Raw Materials Key Suppliers Table 190. NK3 Receptor Antagonists Distributors List Table 191. NK3 Receptor Antagonists Customers List Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. NK3 Receptor Antagonists Image Figure 2. Global NK3 Receptor Antagonists Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global NK3 Receptor Antagonists Market Size Share 2021 VS 2025 VS 2032 Figure 4. 45 mg Dose Image Figure 5. 30 mg Dose Image Figure 6. Global NK3 Receptor Antagonists Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global NK3 Receptor Antagonists Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Specialty Clinic Image Figure 10. Global NK3 Receptor Antagonists Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global NK3 Receptor Antagonists Revenue (2021-2032) & (US$ Million) Figure 12. Global NK3 Receptor Antagonists Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global NK3 Receptor Antagonists Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global NK3 Receptor Antagonists Revenue Market Share by Region (2021-2032) Figure 15. Global NK3 Receptor Antagonists Sales (2021-2032) & (k units) Figure 16. Global NK3 Receptor Antagonists Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global NK3 Receptor Antagonists Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico NK3 Receptor Antagonists Sales YoY (2021-2032) & (k units) Figure 19. Europe NK3 Receptor Antagonists Sales YoY (2021-2032) & (k units) Figure 20. China NK3 Receptor Antagonists Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) NK3 Receptor Antagonists Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa NK3 Receptor Antagonists Sales YoY (2021-2032) & (k units) Figure 23. Global NK3 Receptor Antagonists Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global NK3 Receptor Antagonists Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global NK3 Receptor Antagonists Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global NK3 Receptor Antagonists Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global NK3 Receptor Antagonists Revenue Market Share by Type (2021-2032) Figure 29. Global NK3 Receptor Antagonists Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global NK3 Receptor Antagonists Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global NK3 Receptor Antagonists Sales Market Share by Type (2021-2032) Figure 32. Global NK3 Receptor Antagonists Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global NK3 Receptor Antagonists Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global NK3 Receptor Antagonists Revenue Market Share by Application (2021-2032) Figure 35. Global NK3 Receptor Antagonists Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global NK3 Receptor Antagonists Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global NK3 Receptor Antagonists Sales Market Share by Application (2021-2032) Figure 38. North America NK3 Receptor Antagonists Revenue Share by Type (2021-2032) Figure 39. North America NK3 Receptor Antagonists Sales Share by Type (2021-2032) Figure 40. North America NK3 Receptor Antagonists Revenue Share by Application (2021-2032) Figure 41. North America NK3 Receptor Antagonists Sales Share by Application (2021-2032) Figure 42. North America NK3 Receptor Antagonists Revenue Share by Country (2021-2032) Figure 43. North America NK3 Receptor Antagonists Sales Share by Country (2021-2032) Figure 44. Europe NK3 Receptor Antagonists Revenue Share by Type (2021-2032) Figure 45. Europe NK3 Receptor Antagonists Sales Share by Type (2021-2032) Figure 46. Europe NK3 Receptor Antagonists Revenue Share by Application (2021-2032) Figure 47. Europe NK3 Receptor Antagonists Sales Share by Application (2021-2032) Figure 48. Europe NK3 Receptor Antagonists Revenue Share by Country (2021-2032) Figure 49. Europe NK3 Receptor Antagonists Sales Share by Country (2021-2032) Figure 50. China NK3 Receptor Antagonists Revenue Share by Type (2021-2032) Figure 51. China NK3 Receptor Antagonists Sales Share by Type (2021-2032) Figure 52. China NK3 Receptor Antagonists Revenue Share by Application (2021-2032) Figure 53. China NK3 Receptor Antagonists Sales Share by Application (2021-2032) Figure 54. Asia NK3 Receptor Antagonists Revenue Share by Type (2021-2032) Figure 55. Asia NK3 Receptor Antagonists Sales Share by Type (2021-2032) Figure 56. Asia NK3 Receptor Antagonists Revenue Share by Application (2021-2032) Figure 57. Asia NK3 Receptor Antagonists Sales Share by Application (2021-2032) Figure 58. Asia NK3 Receptor Antagonists Revenue Share by Country (2021-2032) Figure 59. Asia NK3 Receptor Antagonists Sales Share by Country (2021-2032) Figure 60. SAMEA NK3 Receptor Antagonists Revenue Share by Type (2021-2032) Figure 61. SAMEA NK3 Receptor Antagonists Sales Share by Type (2021-2032) Figure 62. SAMEA NK3 Receptor Antagonists Revenue Share by Application (2021-2032) Figure 63. SAMEA NK3 Receptor Antagonists Sales Share by Application (2021-2032) Figure 64. SAMEA NK3 Receptor Antagonists Revenue Share by Country (2021-2032) Figure 65. SAMEA NK3 Receptor Antagonists Sales Share by Country (2021-2032) Figure 66. NK3 Receptor Antagonists Value Chain Figure 67. Manufacturing Cost Structure Figure 68. NK3 Receptor Antagonists Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 45 mg Dose
  • 30 mg Dose
Applications
  • Hospital
  • Specialty Clinic
Companies covered
  • Astellas
  • Bayer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 NK3 Receptor Antagonists Market by Type
  3. 1.2.1 Global NK3 Receptor Antagonists Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 45 mg Dose
  5. 1.2.3 30 mg Dose
  6. 1.3 NK3 Receptor Antagonists Market by Application
  7. 1.3.1 Global NK3 Receptor Antagonists Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Specialty Clinic
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 NK3 Receptor Antagonists Market Dynamics
  1. 2.1 NK3 Receptor Antagonists Industry Trends
  2. 2.2 NK3 Receptor Antagonists Industry Drivers
  3. 2.3 NK3 Receptor Antagonists Industry Opportunities and Challenges
  4. 2.4 NK3 Receptor Antagonists Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global NK3 Receptor Antagonists Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global NK3 Receptor Antagonists Revenue by Region
  3. 3.2.1 Global NK3 Receptor Antagonists Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global NK3 Receptor Antagonists Revenue by Region (2021-2026)
  5. 3.2.3 Global NK3 Receptor Antagonists Revenue by Region (2027-2032)
  6. 3.2.4 Global NK3 Receptor Antagonists Revenue Market Share by Region (2021-2032)
  7. 3.3 Global NK3 Receptor Antagonists Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global NK3 Receptor Antagonists Sales by Region
  9. 3.4.1 Global NK3 Receptor Antagonists Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global NK3 Receptor Antagonists Sales by Region (2021-2026)
  11. 3.4.3 Global NK3 Receptor Antagonists Sales by Region (2027-2032)
  12. 3.4.4 Global NK3 Receptor Antagonists Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global NK3 Receptor Antagonists Revenue by Manufacturers
  2. 4.1.1 Global NK3 Receptor Antagonists Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global NK3 Receptor Antagonists Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global NK3 Receptor Antagonists Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global NK3 Receptor Antagonists Sales by Manufacturers
  6. 4.2.1 Global NK3 Receptor Antagonists Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global NK3 Receptor Antagonists Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global NK3 Receptor Antagonists Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global NK3 Receptor Antagonists Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global NK3 Receptor Antagonists Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global NK3 Receptor Antagonists Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global NK3 Receptor Antagonists Manufacturers, Product Type & Application
  13. 4.7 Global NK3 Receptor Antagonists Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global NK3 Receptor Antagonists Market CR5 and HHI
  16. 4.8.2 2025 NK3 Receptor Antagonists Tier 1, Tier 2, and Tier 3
5 NK3 Receptor Antagonists Market by Type
  1. 5.1 Global NK3 Receptor Antagonists Revenue by Type
  2. 5.1.1 Global NK3 Receptor Antagonists Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global NK3 Receptor Antagonists Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global NK3 Receptor Antagonists Revenue Market Share by Type (2021-2032)
  5. 5.2 Global NK3 Receptor Antagonists Sales by Type
  6. 5.2.1 Global NK3 Receptor Antagonists Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global NK3 Receptor Antagonists Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global NK3 Receptor Antagonists Sales Market Share by Type (2021-2032)
  9. 5.3 Global NK3 Receptor Antagonists Price by Type
6 NK3 Receptor Antagonists Market by Application
  1. 6.1 Global NK3 Receptor Antagonists Revenue by Application
  2. 6.1.1 Global NK3 Receptor Antagonists Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global NK3 Receptor Antagonists Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global NK3 Receptor Antagonists Revenue Market Share by Application (2021-2032)
  5. 6.2 Global NK3 Receptor Antagonists Sales by Application
  6. 6.2.1 Global NK3 Receptor Antagonists Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global NK3 Receptor Antagonists Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global NK3 Receptor Antagonists Sales Market Share by Application (2021-2032)
  9. 6.3 Global NK3 Receptor Antagonists Price by Application
7 Company Profiles
  1. 7.1 Astellas
  2. 7.1.1 Astellas Company Information
  3. 7.1.2 Astellas Business Overview
  4. 7.1.3 Astellas NK3 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Astellas NK3 Receptor Antagonists Product Portfolio
  6. 7.1.5 Astellas Recent Developments
  7. 7.2 Bayer
  8. 7.2.1 Bayer Company Information
  9. 7.2.2 Bayer Business Overview
  10. 7.2.3 Bayer NK3 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bayer NK3 Receptor Antagonists Product Portfolio
  12. 7.2.5 Bayer Recent Developments
8 North America
  1. 8.1 North America NK3 Receptor Antagonists Market Size by Type
  2. 8.1.1 North America NK3 Receptor Antagonists Revenue by Type (2021-2032)
  3. 8.1.2 North America NK3 Receptor Antagonists Sales by Type (2021-2032)
  4. 8.1.3 North America NK3 Receptor Antagonists Price by Type (2021-2032)
  5. 8.2 North America NK3 Receptor Antagonists Market Size by Application
  6. 8.2.1 North America NK3 Receptor Antagonists Revenue by Application (2021-2032)
  7. 8.2.2 North America NK3 Receptor Antagonists Sales by Application (2021-2032)
  8. 8.2.3 North America NK3 Receptor Antagonists Price by Application (2021-2032)
  9. 8.3 North America NK3 Receptor Antagonists Market Size by Country
  10. 8.3.1 North America NK3 Receptor Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America NK3 Receptor Antagonists Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America NK3 Receptor Antagonists Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe NK3 Receptor Antagonists Market Size by Type
  2. 9.1.1 Europe NK3 Receptor Antagonists Revenue by Type (2021-2032)
  3. 9.1.2 Europe NK3 Receptor Antagonists Sales by Type (2021-2032)
  4. 9.1.3 Europe NK3 Receptor Antagonists Price by Type (2021-2032)
  5. 9.2 Europe NK3 Receptor Antagonists Market Size by Application
  6. 9.2.1 Europe NK3 Receptor Antagonists Revenue by Application (2021-2032)
  7. 9.2.2 Europe NK3 Receptor Antagonists Sales by Application (2021-2032)
  8. 9.2.3 Europe NK3 Receptor Antagonists Price by Application (2021-2032)
  9. 9.3 Europe NK3 Receptor Antagonists Market Size by Country
  10. 9.3.1 Europe NK3 Receptor Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe NK3 Receptor Antagonists Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe NK3 Receptor Antagonists Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China NK3 Receptor Antagonists Market Size by Type
  2. 10.1.1 China NK3 Receptor Antagonists Revenue by Type (2021-2032)
  3. 10.1.2 China NK3 Receptor Antagonists Sales by Type (2021-2032)
  4. 10.1.3 China NK3 Receptor Antagonists Price by Type (2021-2032)
  5. 10.2 China NK3 Receptor Antagonists Market Size by Application
  6. 10.2.1 China NK3 Receptor Antagonists Revenue by Application (2021-2032)
  7. 10.2.2 China NK3 Receptor Antagonists Sales by Application (2021-2032)
  8. 10.2.3 China NK3 Receptor Antagonists Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia NK3 Receptor Antagonists Market Size by Type
  2. 11.1.1 Asia NK3 Receptor Antagonists Revenue by Type (2021-2032)
  3. 11.1.2 Asia NK3 Receptor Antagonists Sales by Type (2021-2032)
  4. 11.1.3 Asia NK3 Receptor Antagonists Price by Type (2021-2032)
  5. 11.2 Asia NK3 Receptor Antagonists Market Size by Application
  6. 11.2.1 Asia NK3 Receptor Antagonists Revenue by Application (2021-2032)
  7. 11.2.2 Asia NK3 Receptor Antagonists Sales by Application (2021-2032)
  8. 11.2.3 Asia NK3 Receptor Antagonists Price by Application (2021-2032)
  9. 11.3 Asia NK3 Receptor Antagonists Market Size by Country
  10. 11.3.1 Asia NK3 Receptor Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia NK3 Receptor Antagonists Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia NK3 Receptor Antagonists Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA NK3 Receptor Antagonists Market Size by Type
  2. 12.1.1 SAMEA NK3 Receptor Antagonists Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA NK3 Receptor Antagonists Sales by Type (2021-2032)
  4. 12.1.3 SAMEA NK3 Receptor Antagonists Price by Type (2021-2032)
  5. 12.2 SAMEA NK3 Receptor Antagonists Market Size by Application
  6. 12.2.1 SAMEA NK3 Receptor Antagonists Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA NK3 Receptor Antagonists Sales by Application (2021-2032)
  8. 12.2.3 SAMEA NK3 Receptor Antagonists Price by Application (2021-2032)
  9. 12.3 SAMEA NK3 Receptor Antagonists Market Size by Country
  10. 12.3.1 SAMEA NK3 Receptor Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA NK3 Receptor Antagonists Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA NK3 Receptor Antagonists Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 NK3 Receptor Antagonists Value Chain Analysis
  2. 13.1.1 NK3 Receptor Antagonists Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 NK3 Receptor Antagonists Production Mode & Process
  6. 13.2 NK3 Receptor Antagonists Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 NK3 Receptor Antagonists Distributors
  9. 13.2.3 NK3 Receptor Antagonists Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst